https://www.live-feeds.com/feed/women-travel-thousands-of-miles-for-a-reproductive-moonshot-scientists-say-they-ve-been-misledContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/women-travel-thousands-of-miles-for-a-reproductive-moonshot-scientists-say-they-ve-been-misledhttps://www.live-feeds.com/feed/women-travel-thousands-of-miles-for-a-reproductive-moonshot-scientists-say-they-ve-been-misled#u182585Fri, 06 Nov 2026 20:42:02 +0000International Fertility Group of North America has paused marketing mitochondrial replacement therapy for age-related infertility following a STAT investigation. The probe found that a technique designed to prevent mitochondrial disease inheritance is being sold globally as a fertility treatment for older women despite limited evidence of its effectiveness. Some women paid a U.S. broker between $20,000 and $30,000 to access these overseas procedures. Scientists warn that patients have been misled about the benefits of this experimental approach.Why it mattersMitochondrial replacement therapy,